March 8, 2013
GSK submits albiglutide for European approval – PMLiVE
GlaxoSmithKline (GSK) has submitted its albiglutide once-weekly injection for type 2 diabetes to European regulators.…
March 7, 2013
The Promise — and Perils — of Personalized Medicine
Personalized medicine -- the ability to tailor therapies to patients' individual genetic characteristics -- has…
March 7, 2013
Nanomedicines Alliance Industry Symposium
NANOMEDICINES: CHARTING A ROADMAP TO COMMERCIALIZATION On 6-7 March 2013, the Nanomedicines Alliance will be…
March 5, 2013
University Startups Conference 2013: Registration
NOW IN ITS 7th YEAR! University Startups Showcase and Conference 2013 March 20-22, 2013 Washington…
March 4, 2013
BioHealth Innovation, Inc. President & CEO Richard Bendis to Present at SXSW 2013 & 2013 BIO International Convention
ROCKVILLE, MARYLAND, March 4, 2013 – BioHealth Innovation, Inc. (BHI), a regional private-public partnership focusing on…